A

Adial Pharmaceuticals

D
ADIL
USD
0.055
(5.4187%)
Market Closed
1,528.00
Volume
-3.46
EPS
-
Div Yield
-0.268170
P/E
6,851,617.67
Market Cap
Today
5.4187%
1 Week
8.081%
1 Month
11.458%
6 Months
-30.968%
12 Months
-52.863%
Year To Date
-44.271%
All Time
-98.979%
News

Treasury Yields Decline as Market Anticipates Fed Rate Cuts

26.08.2024
Economy news

Novo Nordisk Surges in Profit and Sales

02.05.2024
Stocks news
More
Related Instruments
0.0001490405
(0.4045%)
USD

Title:
Adial Pharmaceuticals

Sector:
Healthcare
Industry:
Biotechnology
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
Do you need help or have a question?
Contact Us